NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.39% | 42.57% | 45.62% | -30.23% | 20.89% |
| Total Depreciation and Amortization | -34.38% | -49.72% | -13.94% | -0.64% | 1.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.72% | -46.32% | 10.34% | 12.92% | 15.52% |
| Change in Net Operating Assets | 226.33% | 90.23% | -303.17% | 609.04% | 103.69% |
| Cash from Operations | 14.23% | 58.58% | 19.92% | -20.81% | 50.92% |
| Capital Expenditure | -- | -- | 100.00% | 80.00% | 88.29% |
| Sale of Property, Plant, and Equipment | -91.66% | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -91.66% | -- | -100.00% | 164.00% | 88.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -262.25% | 121.44% | 19.89% | -20.66% | 51.05% |
